On the origin of matrix metalloproteinase-2 and -9 in blood platelets.
To date, several matrix metalloproteinases (MMPs) have been identified in human platelets. In most research studies, the platelets are obtained using the isolation method from plasma by centrifugation and washing. The metalloproteinase content in the platelets can be affected by the isolation technique and the leukocyte contamination. In this work, we studied the influence of the isolation method on the detection of platelet MMPs and explore the expression of these enzymes in megakaryoblastic MEG-01 cells. We investigated the expression of mRNAs encoding for MMP-2 and -9 in platelets and MEG-01 cells. Using gelatin zymography and western blotting, we examined the expression and release of MMP-2 and 9 by platelets and MEG-01 cells and checked whether the amount of the released MMPs depends on the volume of tested platelet and leukocyte contamination. To investigate the MMP-2 expression profile, we used zymography and flow cytometry. Platelets, in contrast to the MEG-01 cells, neither contain mRNA for MMP-2 nor -9. The platelets contain pro-MMP-2 and release it during the activation. The population of uncontaminated (leukocytes<0.02%) platelets contained no MMP-9 or the active form of MMP-2. We have observed that the activity of MMP-2 in platelet lysate is proportional to their mean volume and that the MMP-2 activity may not be detected if very small platelets are examined. We conclude that the detection of gelatinases in platelets depends on platelet isolation techniques and the degree of leukocyte contamination.
Department of Medical Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland. aneta.wrzyszcz@am.wroc.pl
Aneta
A
Wrzyszcz
Mieczyslaw
M
Wozniak
D016477:Artifacts; D001792:Blood Platelets / Q000166:cytology / Q000201:enzymology*; D015153:Blotting, Western; D002460:Cell Line; D002469:Cell Separation / Q000379:methods; D048429:Cell Size; D004792:Enzyme Precursors / Q000235:genetics* / Q000378:metabolism; D005434:Flow Cytometry; D006801:Humans; D007962:Leukocytes; D020778:Matrix Metalloproteinase 2 / Q000235:genetics* / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000235:genetics* / Q000378:metabolism; D055016:Megakaryocyte Progenitor Cells / Q000166:cytology / Q000201:enzymology*; D015539:Platelet Activation / Q000187:drug effects; D012333:RNA, Messenger / Q000096:biosynthesis; D013917:Thrombin / Q000494:pharmacology; D014158:Transcription, Genetic
D004792:Enzyme Precursors; D012333:RNA, Messenger; D013917:Thrombin; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9